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imitations of
omputed Tomography
oronary Angiography*
teven E. Nissen, MD, MACC
leveland, Ohio
t seems so simple and elegant. Fifty years after the
ntroduction of coronary angiography, advances in technol-
gy allow imaging of the coronary arteries noninvasively
sing multidetector computed tomography (CT) scanners
1). Within a few short years, these imaging systems have
egun appearing everywhere, first in hospitals and clinics,
hen in individual doctors’ offices, offering the promise of
afe and painless detection of coronary obstructions (2).
eekend courses allow the members of our profession to
learn” this new technology and apply it routinely to patient
are (3). The manufacturers of the equipment, all large
ultinational providers of radiological imaging devices, are
uite pleased to show practitioners how they can rapidly
ecoup their million-dollar investments (4,5). What could
ossibly be wrong with this picture? Medical progress to the
etterment of patients (and practitioners).
See page 2135
n this issue of the Journal, an interesting and important
aper by Meijboom et al. (6) provides data that should give
s pause. When applied routinely in symptomatic patients
t risk of coronary disease, in more than 50% of subjects,
T angiography “detected” coronary obstructions that sim-
ly were not there. Strikingly, of 98 patients in whom CT
ngiography diagnosed 3-vessel coronary artery disease
CAD), only 19 actually were found to have it, a false-
ositive rate of 81%. This high false-positive rate has
otentially serious implications, leading to unnecessary and
otentially risky procedures that threaten to accelerate
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
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ees directly to charity so that he receives neither income nor a tax deduction.lready-excessive health care costs. Now that our national
ealth care expenditures exceed 16% of the gross national
roduct, we must ask ourselves critical questions about the
ntroduction of any costly new technology. Does it improve
uality of care compared with existing methods? Does it
rolong life or improve quality of life? Does it reduce costs?
s it cost-effective? Are there important safety concerns?
espite its rapid adoption, for all of these metrics, CT
oronary angiography has yet to show that it can deliver on
ts promise.
Routine application of CT angiography is largely based
n flawed assumptions about the nature of CAD. After the
ntroduction of angiography by Sones in 1957, a generation
f practitioners came to believe that coronary disease could
est be defined by the presence or absence of obstructive
esions. This view was reinforced by the introduction of
ypass surgery in 1968. Coronary disease was simple. If you
ad enough obstructions, you carried a high risk for mor-
idity and mortality, and would benefit from surgical
evascularization. If there were no obstructions, CAD was
ot present. Then, a decade later, Andreas Gruntzig intro-
uced balloon angioplasty, and luminal obstructions could
e readily treated without surgery. Within a few years, an
ntirely new discipline, interventional cardiology, was cre-
ted, rapidly growing into the dominant approach used to
reat stable CAD.
imitations of Angiography
hen came disquieting research. Most myocardial infarc-
ions did not occur at the sites of significant coronary
arrowing, and percutaneous treatment of coronary obstruc-
ions in patients with stable angina did not reduce the risk
f myocardial infarction or death (7,8). Whether performed
nvasively or via multidetector CT, angiography is con-
ounded by the phenomenon of coronary remodeling, first
escribed in 1987 by Glagov et al. (9). The remodeling
rocess is observed histologically as the outward displace-
ent of the external vessel wall overlying the atheroma. The
dventitial enlargement opposes luminal encroachment,
hereby concealing the presence of disease. Thus, the vessel
all may contain a large atheroma, despite an angiogram
hat shows little or no luminal narrowing. Although remod-
led lesions do not restrict blood flow, clinical studies have
hown that these low-grade lesions represent the most
mportant source of acute coronary syndromes (10). Accord-
ngly, an absence of luminal narrowing does not preclude a
isk of plaque rupture, resulting in myocardial infarction or
udden cardiac death. It must be acknowledged that a
otential advantage of CT angiography is detection of these
onobstructive plaques, but the clinical utility of such
ssessments remains unproven.
Beginning soon after the introduction of coronary an-
iography, studies began to question the accuracy and
eproducibility of angiography. Carefully performed inves-
igations demonstrated that visual interpretation of angiog-
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CT Coronary Angiography Limitations December 16/23, 2008:2145–7aphy showed clinically significant intraobserver and inter-
bserver variability (11). Other investigators documented
ajor differences between the apparent angiographic sever-
ty of lesions and the extent of disease at post-mortem
xamination (12). Then, using functional testing, studies
howed a prominent discordance between the apparent
ngiographic severity of lesions and the physiological effects
f stenoses (13). We learned the difficult lesson, now
pparently forgotten, that the silhouette or luminogram is a
elatively poor representation of coronary anatomy and a
imited standard on which to base therapeutic decisions (14).
unctional Testing
ccordingly, cardiovascular medicine evolved to use func-
ional testing to assess the likelihood that symptoms were
elated to impaired coronary blood flow. Because luminal
arrowing alone did not accurately identify patients who
ould benefit from revascularization, practitioners began
outinely evaluating symptomatic patients for the presence
f physiological abnormalities associated with these obstruc-
ions. This approach was logical, although its cost effective-
ess has not been rigorously studied. If there was good
xercise capacity and no ischemia, angiography and inter-
ention could be safely deferred. In some cases, functional
esting was performed after angiography, rather than before,
o determine whether a lesion observed by angiography
ctually represented a flow-limiting stenosis. Two compet-
ng imaging technologies developed, first exercise nuclear
cintigraphy, and subsequently, stress echocardiography.
or patients who could not exercise, elegant pharmacolog-
cal approaches were developed to substitute for exercise
esting. Of equal importance, the exercise capacity and
agnitude of the ischemic burden provided valuable prog-
ostic information that could be used to guide therapy.
nfortunately, the rapid proliferation of CT angiography
hreatens to take us back to the overly simplistic approach of
ur predecessors, once described as “our preoccupation with
oronary luminology” (14). Just find the stenosis and treat it
ggressively, an approach sarcastically described as the
culostenotic reflex (14).
T Angiography: A Step Backward
ompared with conventional angiography, the angiograms
roduced by multidetector CT scanners are much lower in
uality and are suboptimal for diagnostic purposes. To
nderstand the deficiencies in CT angiography, it is impor-
ant to review the physics of the technology used for
oronary angiography. The resolution of modern angio-
raphic equipment is surprisingly modest, only about 4 or 5
ine pairs per millimeter. Prudence limits radiation expo-
ure, resulting in an image flaw known as quantum statis-
ical noise that can be reduced only by increasing radiation
oses. Angiographic resolution is also compromised by
apid coronary artery motion, which is reduced in impact for
onventional angiography by using pulse-mode radiogra- ahy. The translational velocity of the right coronary artery
an reach 50 mm/s. A coronary artery moving at 50 mm/s
ill produce a motion blur of approximately 0.35 mm
uring a typical 7-ms X-ray pulse width, an acceptable
emporal resolution for high-quality angiographic imaging.
CT angiography represents a step backward in image
uality. The spatial resolution is only about 2 line pairs per
illimeter, about one-half that of conventional angiography
15). The temporal resolution of CT angiography is very
oor, currently about 20-fold worse than a typical conven-
ional angiogram (150 ms) (15). To overcome the limi-
ations in temporal resolution, electrocardiographic gating is
sed, but rarely represents a perfect solution and precludes
uccessfully imaging in patients with arrhythmias such as
trial fibrillation. Even more problematic, the presence of
oronary calcium frequently obscures the underlying lumen,
endering the imaging of specific stenoses unreliable. Ac-
ordingly, CT angiography retains all of the limitations of
onventional angiography, including the absence of physi-
logical information and poor correlation with histology,
ut it is further constrained by poor image quality. With
hese limitations, it is not surprising that CT angiography
erformed poorly in the current study.
To overcome quantum statistical noise and other quality
imitations, large radiation dosages are used, typically aver-
ging 15 mSv, with specific organ systems receiving
ubstantially higher exposure levels, about 5 to 7 times the
osage used by prudent practitioners in an optimal invasive
ngiogram (16). Recent studies suggest a small but impor-
ant risk of inducing malignancy, ranging as high as 1 in 150
or breast cancer in a younger woman (16). Practitioners
lso must consider the likelihood that many patients will
ndure multiple CT scans during their lifetime, amplifying
he radiation risk.
oronary Flow Reserve (CFR)
hy should we prefer functional testing to anatomical
ethods such as CT angiography? In chronic ischemic
oronary disease, symptoms result principally from the
bility of stenoses to blunt increases in blood flow in
esponse to metabolic demands. This phenomenon is com-
only called CFR (17). Animal studies show that CFR
emains normal (typically a 5- to 7-fold increase in flow)
ntil the stenosis approaches 75%. Between 75% and 95%,
FR decreases progressively. Accordingly, the angiographic
ifferences between moderate and severe lesions may be only
few tenths of a millimeter. Such differences are difficult to
iscern given the limitations in resolution of the best
onventional angiography and impossible to resolve with
T angiography. Other factors impair the correlation be-
ween angiographic lesion severity and CFR, including the
resence of ventricular hypertrophy, the metabolic state of
he myocardium, and microvascular disease. Thus, the
picardial stenosis represents only one factor responsible for
reduction in flow reserve in patients with clinical symp-
t
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December 16/23, 2008:2145–7 CT Coronary Angiography Limitationsoms. A stenosis incapable of producing angina in one
atient may result in severe functional limitation in another.
ccordingly, testing for the presence of ischemia, rather
han the presence of a stenosis, is essential for good clinical
ecision making.
Some ardent advocates will point out that CT angiogra-
hy and physiological testing are not mutually exclusive.
his advocacy ignores the issue of cost-effectiveness. Test-
ng via multiple imaging modalities has shown neither
uperior effectiveness nor cost savings over current diagnos-
ic paradigms. Proponents also emphasize the negative
redictive value of the test. However, we must consider the
mplications and costs of a false-positive study, which, in
any cases, will lead to additional costly testing or proce-
ures. Therefore, we are now left with a conundrum. CT
ngiography is being deployed rapidly, and there exist no
ncentives for industry or physician advocates to seek the
linical trial data we need to effectively use this imaging
odality. Accordingly, we need a restricted use of CT
ngiography until adequate clinical evidence becomes
vailable showing the cost-effectiveness and safety of this
pproach (18,19). We need real-world trials that use this
echnology, not just in carefully selected patients who
enerate optimal images, but in all comers, including
atients with a low, medium, and high risk of CAD.
inally, we need outcome studies to show whether this new
pproach really improves what we care most about: patient
utcomes.
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